MentionFox
Home › funding signals › Porosome Therapeutics, Inc.
Company · SEC filings

Porosome Therapeutics, Inc. funding history

Porosome Therapeutics, Inc. has 4 Form D filings on record, from 2023-09-14 to 2026-03-24. Together its new offerings report $1.50M sold.

Funding historyFounders and team

What do you want to do with Porosome Therapeutics, Inc.?

Key facts

  • · Type: Amendment first sale 2023-09-08 · Amount sold: $3.63M · SEC filing
  • · Type: Amendment first sale 2023-09-08 · Amount sold: $2.50M · SEC filing
  • · Type: Amendment first sale 2023-09-08 · Amount sold: $1M · SEC filing
  • · Type: New offering first sale 2023-09-08 · Amount sold: $1.50M · Total offering: $5M · SEC filing
Based
BOSTON, MASSACHUSETTS
Year formed
2021
Industry group
Biotechnology
Filings
4
Raised (new offerings)
$1.50M

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-03-24Amendment
first sale 2023-09-08
$3.63M—SEC filing
2025-06-03Amendment
first sale 2023-09-08
$2.50M—SEC filing
2024-07-25Amendment
first sale 2023-09-08
$1M—SEC filing
2023-09-14New offering
first sale 2023-09-08
$1.50M$5MSEC filing

Want the whole picture on Porosome Therapeutics, Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Porosome Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Porosome Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    4 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on Target: the verdict, 16 sections, 39 cited sources, dated 2026-09-28A real finished report, first screen. Opens in a new tab.

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Porosome Therapeutics, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Porosome Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/company/porosome-therapeutics-inc
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Porosome Therapeutics, Inc. funding history: 4 SEC filings, $1.50M raised. MentionFox, 2026-09-27. https://mentionfox.com/company/porosome-therapeutics-inc